We are turning 10!

Join us for a reception on November 30 at the Grand Concourse to see how far we’ve come with your support … and just how far we plan to go.

RSVP Here!

Events Search and Views Navigation

Event Views Navigation

Today

Latest Past Events

Rare Liver Disease Program

December 6, 2023 7:00-9:00 p.m. EST Register Now!   Program Sponsors: *Industry partners must have an exhibit or sponsorship to participate in the Community Liver Alliance programs and events. Your support allows the […]

Post-AASLD

December 5, 2023 6:00-9:00 p.m. EST Virtual CME Program The Community Liver Alliance is planning its 10th Annual Post-AASLD Program led by Course Directors Michael Babich, MD with Allegheny Health […]

10th Anniversary Celebration

Grand Concourse 100 W Station Square Drive, Pittsburgh

                      November 30, 2023 6:00-8:00 p.m. Grand Concourse (Station Square, Pittsburgh) $50 per person Click here to register! The Community […]

Advocacy

Learn More

News & Information

News & Information

Medicare Man

Medicare Cuts Worrisome

Letter to the Editor: Medicare Cuts Worrisome Trib Live September 2021 As I work with Medicare seniors in Pennsylvania, I am concerned about prospective cuts to clinical lab services. In

Read More »
September 17, 2021

Suzanna Masartis Speaks Out for Hep C

Testimony of Suzanna Masartis Executive Director, Community Liver Alliance Joint Informational Meeting of the Pennsylvania House Health and Insurance Committees Monday, April 20, 2015 My name is Suzanna Masartis and

Read More »
October 28, 2021

Advocacy

Liver Disease Does Not Discriminate
There is 80 to 100 million people in the USA that have Fatty Liver Disease and most do not even know they have it. Liver Disease does not discriminate. It affects any age, social economics and race. Liver cancer incidence rates have more than tripled since 1980, while the death rates have more than doubled during this time.
COVID-19 Response
Ensure funding for COVID-19 and liver disease public health programs, research, vaccine dissemination; ensure that people living with liver disease are not disproportionately impacted and do not experience unnecessary or discriminatory health care or treatment disruptions.
Health Disparities
Address inequities in the care of people impacted by liver disease, especially the excess incidence rate of liver cancer in black men in America.
Liver Health Policy
Advance the U.S. NASH Action Plan, and ensure patients with liver disease perspectives are represented in relevant legislative packages: COVID-19, diabetes, and obesity.
Liver Health Regulations
Work with regulators to establish logical pathways to consistently approve therapies for liver diseases, particularly rare liver diseases.
Research Funding
Advocate for funding that ensures meaningful growth of vital liver disease research and the improving of liver health.
Transplant
Urgently respond to the inequities that impact organ transplantation; modernize the U.S. Organ Donation system, improve care for transplant patients, and increase the number of available organs.
Viral Hepatitis
Increase support for hepatitis programs and raise awareness of viral hepatitis; advocate for the elimination of viral hepatitis .
Value
Advance health care policies that reflect each person’s unique needs and drive access to personalized, patient-centric care.
Patient Access and Reimbursement
Support policy solutions that curb patients’ health care expenses; advocate for the smoothing and capping of out-of-pocket costs in Medicare Part D.
Previous
Next
Learn More
0
PEOPLE IN USA WITH LIVER DISEASE
0
PEOPLE IN USA WITH FATTY LIVER DISEASE
0 %
RISE IN LIVER CANCER SINCE 1980
thumbnail_candy
a5b522_bb2badba75194f0ca50fa9f4b1eb9bd3_mv2_d_5184_3456_s_4_2 (1)
a5b522_3be131b09ce34a6381cb85f997038b37_mv2_d_4000_3000_s_4_2
CLA Event 4
CLA Event 2
CLA Event 3
CLA Event 1
20220727_125343